Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PSMC3IP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TRIM23 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EPB41 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
TIMM21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DCAF7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ETAA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BRIP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HOMER1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PEX13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OGT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
APPL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPFIBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBBP6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMIM7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on